Specific inhibition of epidermal growth factor receptor tyrosine kinase by 4-anilinoquinazolines (original) (raw)

Access this article

Log in via an institution

Subscribe and save

• Starting from 10 chapters or articles per month
• Access and download chapters and articles from more than 300k books and 2,500 journals
• Cancel anytime View plans

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

1. Sainsbury JRC, Malcolm AJ, Appleton DR, Farndon JR, Harris AL: Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer. J Clin Pathol 38:1225–1228, 1985.
   PubMed Google Scholar
2. Gullick WJ: Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers. Br Med Bull 47:87–98, 1991.
   Google Scholar
3. Rajkumar T, Gullick WJ: The Type I growth factor receptors in human breast cancer. Breast Cancer Res Treat 29:3–9, 1994.
   PubMed Google Scholar
4. Yarden Y, Ullrich A: Growth factor receptor tyrosine kinases. Ann Rev Biochem 57:443–478, 1998.
   Google Scholar
5. Schlessinger J: How receptor tyrosine kinases activate Ras. Trends Biochem Sci 18:273–275, 1993.
   PubMed Google Scholar
6. Ennis BW, Lippman ME, Dickson RB: The EGF receptor system as a target for antitumor therapy. Cancer Investigation 9:553–562, 1991.
   PubMed Google Scholar
7. Workman P: The potential for molecular oncology to define new drug targets.In Kerr DJ, Workman P (eds) New Molecular Targets for Cancer Chemotherapy. CRC Press, London, 1994, pp 1–29.
   Google Scholar
8. Burke TR Jr: Protein-tyrosine kinase inhibitors. Drugs of the Future 17:119–131, 1992.
   Google Scholar
9. Hanks SK: Eukaryotic protein kinases. Current Opin Struct Biol 1:369–383, 1991.
   Google Scholar
10. Yaish P, Gazit A, Gilon C, Levitzki A: Blocking of EGF-dependent cell proliferation by EGF receptor kinase inhibitors. Science 242:933–935, 1988.
    PubMed Google Scholar
11. Ward WHJ, Cook PN, Slater AM, Davies DH, Holdgate GA, Green LR: Epidermal growth factor receptor tyrosine kinase. Investigation of catalytic mechanism, structure-based searching and discovery of a potent inhibitor. Biochem Pharmacol 48:659–666, 1994.
    PubMed Google Scholar
12. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 56:55–63, 1983.
    PubMed Google Scholar
13. Posner I, Engel M, Levitzki A: Kinetic model of the epidermal growth factor (EGF)-receptor tyrosine kinase and a possible mechanism of its activation by EGF. J Biol Chem 267:20638–20647, 1992.
    PubMed Google Scholar
14. Levitzki A: Tyrphostins — potential antiproliferative agents and novel molecular tools. Biochem Pharmacol 40:913–918, 1990.
    PubMed Google Scholar
15. Thompson AM, Rewcastle GW, Tercel M, Dobrusin EM, Fry DW, Kraker AJ, Denny WA: Tyrosine kinase inhibitors. 1. Structure-activity relationships for inhibition of epidermal growth factor receptor tyrosine kinase activity by 2,4-dihydro-2-thioxo-1_H_-indole-3-alkanoic acids and 2,2'-dithiobis(1_H_-indole-3-alkanoic acids). J Med Chem 36:2459–2469, 1993.
    PubMed Google Scholar
16. Buchdunger E, Trinks U, Mett H, Regenass U, Muller M, Meyer T, McGlynn E, Pinna LA, Traxler P, Lydon NB: 4,5-dianilinophthalimide: a protein-tyrosine kinase inhibitor with selectivity for the epidermal growth factor receptor signal transduction pathway and potent_in vivo_ antitumor activity. Proc Natl Acad Sci USA 91:2334–2338, 1994.
    PubMed Google Scholar
17. Fry DW, Kraker AJ, McMichael A, Ambroso LA, Nelson JM, Leopold WR, Connors RW, Bridges AJ: A specific inhibitor of epidermal growth factor receptor tyrosine kinase. Science 265:1093–1095, 1994.
    PubMed Google Scholar
18. Osherov N, Gazit A, Gilon C, Levitzki A: Selective inhibition of the epidermal growth factor and HER2/Neu receptors by tyrphostins. J Biol Chem 268: 11134–11142, 1993.
    PubMed Google Scholar
19. Vignon F, Bouton M-M, Rochefort H: Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens. Biochem Biophys Res Commun 146:1502–1508, 1987.
    PubMed Google Scholar
20. Koga M, Sutherland RL: Epidermal growth factor partially reverses the inhibitory effects of antioestrogens on T47D human breast cancer cell growth. Biochem Biophys Res Commun 146:739–747, 1987.
    PubMed Google Scholar
21. Wakeling AE, Newboult E, Peters SW: Effects of antioestrogens on the proliferation of MCF-7 human breast cancer cells. J Molec Endocr 2:225–234, 1989.
    Google Scholar
22. Ignar-Trowbridge DM, Nelson KG, Bidwell MC, Curtis SW, Washburn TF, McLachlan JA, Korach KS: Coupling of dual signalling pathways: Epidermal growth factor action involves the estrogen receptor. Proc Natl Acad Sci USA 89:4658–4662, 1992.
    PubMed Google Scholar
23. Newton CJ, Buric R, Trapp T, Brockmeier S, Pagotto U, Stalla GK: The unliganded estrogen receptor (ER) transduces growth factor signals. J Steroid Biochem Mol Biol 48:481–486, 1994.
    PubMed Google Scholar
24. Reddy KB, Mangold GL, Tandon AK, Yoneda T, Mundy GR, Zilberstein A, Osborne CK: Inhibition of breast cancer cell growth_in vitro_ by a tyrosine kinase inhibitor. Cancer Res 52:3636–3641, 1992.
    PubMed Google Scholar
25. Yoneda T, Lyall RM, Alsina MM, Persons PE, Spada AP, Levitzki A, Zilberstein A, Mundy GR: The antiproliferative effects of tyrosine kinase inhibitors tyrphostins on a human squamous cell carcinoma_in vitro_ and in nude mice. Cancer Res 51:4430–4435, 1991.
    PubMed Google Scholar

Download references